Found 376 articles for: "Open Access"
Practical Algorithm Guiding Seborrheic Dermatitis Treatment in Adults and Adolescents: New Evidence and Consensus Expert Opinion
November 2026 | Volume 25 | Issue 11 | Original Article | 1019 | Copyright © November 2026
Background: Seborrheic dermatitis (SD) is a common, chronic inflammatory skin disease characterized by greasy, scaly plaques on the scalp or body, often with pruritus and impaired ...
Read MoreFULL SUPPLEMENT: Emerging Technologies to Manage Grey Hair
November 2026 | Volume 25 | Issue 11 | Department | 932700 | Copyright © November 2026
Greying of hair, also called canities or achromotrichia, is part of the natural aging process. It has been reported ...
Read MoreINDIVIDUAL ARTICLE: Randomized Double-Blind, Placebo-Controlled Study of a Supplement and Serum on Grey Hair
November 2026 | Volume 25 | Issue 11 | Supplement Individual Articles | 932701 | Copyright © November 2026
Worldwide, 74% of men and women between the ages of 45 and 65 have some grey hair. Currently, there is no treatment that has been shown in a clinical trial to repigment or slow the development of...
Read MoreA Moisturizer With Centella asiatica and Mandelic Acid Reduces Bruising and Speeds Recovery in Mature Skin
November 2026 | Volume 25 | Issue 11 | Original Article | 1059 | Copyright © November 2026
Background: Dermatoporosis is a chronic cutaneous insufficiency syndrome characterized by skin atrophy, purpura, bruising, delayed healing, and increased injury susceptibility. T...
Read MoreTranexamic Acid Mesotherapy for Melasma: An Interventional Study
November 2026 | Volume 25 | Issue 11 | Original Article | 1066 | Copyright © November 2026
Background: Tranexamic acid (TXA), an anti-fibrinolytic agent traditionally used to manage blood loss, has shown promising results in the treatment of melasma. Studies on the eff...
Read MoreGenerative Artificial Intelligence Augmentation of a Clinical Trial of a Dermo-cosmetic Intervention for Acne Remission Maintenance
November 2026 | Volume 25 | Issue 11 | Original Article | 1014 | Copyright © November 2026
Background: A practical application of artificial intelligence (AI) in healthcare is to generate artificial datasets that capture the characteristics of a real source dataset wit...
Read MoreImpetigo Antibiotic Stewardship and the Need for Treatment Alternatives
November 2026 | Volume 25 | Issue 11 | Original Article | 1003 | Copyright © November 2026
Background: Impetigo is a highly contagious bacterial skin infection, primarily caused by Staphylococcus aureus and, less frequently, Streptococcus pyogenes. Although typically s...
Read MoreIncreased Risk of Skin Cancers in Certain Occupations
November 2026 | Volume 25 | Issue 11 | Original Article | 1010 | Copyright © November 2026
Ultraviolet radiation (UVR) is the main risk factor for the development of skin cancer, and outdoor workers are especially at risk. Despite this, there is a lack of educational programs, and prev...
Read MoreFULL SUPPLEMENT: Tildrakizumab In Everyday Dermatology: Clinical Insights From Challenging Psoriasis Cases
October 2026 | Volume 25 | Issue 10 | Department | 435800s1 | Copyright © October 2026
Tildrakizumab is a humanized immunoglobulin G1 (IgG1) monoclonal antibody that selectively binds the p19 subunit of interleukin-23 (IL-23), a key cytokine in the pathogenesis of psoriasis. In the pivo...
Read MoreINDIVIDUAL ARTICLE: Tildrakizumab for Real-World Psoriasis Care: Clinical Lessons From Medically Complex and Underserved Patient Populations
October 2026 | Volume 25 | Issue 10 | Supplement Individual Articles | 435801s4 | Copyright © October 2026
Tildrakizumab, a humanized monoclonal antibody targeting the p19 subunit of interleukin-23, has demonstrated durable efficacy and a favorable long-term safety profile in moderate-to-severe plaque p...
Read MoreFULL SUPPLEMENT: Ammonium Lactate for Xerotic Skin Conditions: Biomimetic Effects and Clinical Relevance
October 2026 | Volume 25 | Issue 10 | Department | 946300s1 | Copyright © October 2026
Xerosis is a common and clinically significant dermatologic concern, affecting patients across a broad spectrum of conditions, including atopic dermatitis, psoriasis, ichthyosis, and age- or environme...
Read MoreINDIVIDUAL ARTICLE: Ammonium Lactate in Clinical Practice: Optimizing Treatment of Xerotic and Hyperkeratotic Skin Conditions
October 2026 | Volume 25 | Issue 10 | Supplement Individual Articles | 946302s4 | Copyright © October 2026
Ammonium lactate is a well-established, time-tested dermatologic therapy with a substantial body of clinical evidence supporting its use inxerotic and hyperkeratotic skin conditions....
Read MoreINDIVIDUAL ARTICLE: Beyond Moisturization: Ammonium Lactate as a Biomimetic Regulator of Skin Barrier Function
October 2026 | Volume 25 | Issue 10 | Supplement Individual Articles | 946301s10 | Copyright © October 2026
The stratum corneum (SC) is essential for maintaining skin barrier integrity through coordinated interactions between corneocytes, intercellular lipids, and natural moisturizing factors (NMFs). L...
Read MoreFundamentals of Hyperpigmentation Disorders: Causes, Concerns, and Treatment Strategies, Particularly in Skin of Color Patients
October 2026 | Volume 25 | Issue 10 | Original Article | 926 | Copyright © October 2026
Read MoreNordic European Countries Atopic Dermatitis (NECAD) I: Importance of Concordance With Skincare for Atopic Dermatitis
October 2026 | Volume 25 | Issue 10 | Original Article | 949 | Copyright © October 2026
Background: Atopic dermatitis (AD) is a chronic disease with a dysfunctional skin barrier, requiring continuous management to reduce symptoms and prevent flares. Topical treatmen...
Read MoreSAIGE III: The Role of Environmental Factors in the Development and Severity of Atopic Dermatitis in Young Children
October 2026 | Volume 25 | Issue 10 | Original Article | 935 | Copyright © October 2026
Background: Atopic dermatitis (AD) often manifests in infancy or early childhood, with significant impacts on quality of life and potential persistence into adulthood. Environmen...
Read MoreThe Essential Role of Topical Targeted Therapy in Atopic Dermatitis
October 2026 | Volume 25 | Issue 10 | Original Article | 898 | Copyright © October 2026
Background: Atopic dermatitis (AD) is a chronic inflammatory skin disorder marked by immune dysregulation, epidermal barrier dysfunction, microbiome imbalance, pruritus, and xero...
Read MoreHistological Analysis Shows That a Moisturizer Formulated for Dermatoporosis Increases Elastin Content and Improves Skin Elasticity
October 2026 | Volume 25 | Issue 10 | Original Article | 962 | Copyright © October 2026
Background: Dermatoporosis involves age-related alterations in dermal structure and cellular function, including changes in collagen, elastin, and markers of skin senescence. Cha...
Read MoreFULL SUPPLEMENT: The Hidden Burden of Topical Corticosteroids: Integrating Literature, Prescribing Information, and Real-World Evidence
November 2026 | Volume 25 | Issue 11 | Department | 104190s1 | Copyright © November 2026
INDIVIDUAL ARTICLE: Cutaneous and Systemic Adverse Events Associated With Topical Corticosteroid Use: A Targeted Literature Review
November 2026 | Volume 25 | Issue 11 | Supplement Individual Articles | 10419s4 | Copyright © November 2026
Background: Topical corticosteroids (TCS) have been used to treat chronic inflammatory skin conditions since initial approval in 1950, which was followed by reports of cutaneous an...
Read More© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
